STOCK TITAN

PacBio to Report Second Quarter 2022 Financial Results on August 3, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

PacBio (NASDAQ: PACB) will hold its quarterly conference call on August 3, 2022, at 5:00 pm ET to discuss its Q2 2022 financial results. The call will be accessible via webcast on the company's investor relations website. Interested participants can listen online or dial in using toll-free or international numbers. PacBio specializes in advanced sequencing solutions for scientific and clinical research, focusing on accuracy and quality through its HiFi long read and SBB® short read sequencing technologies.

Positive
  • None.
Negative
  • None.

MENLO PARK, Calif., July 18, 2022 /PRNewswire/ -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2022 financial results on Wednesday, August 3, 2022, at 5:00 pm Eastern Time.

The call will be webcast live and may be accessed at PacBio's website at: https://investor.pacificbiosciences.com/.

Date: Wednesday, August 3, 2022

Time: 5:00pm ET (2:00pm PT)

Listen via Internet: https://investor.pacificbiosciences.com/

Toll-free: 866-652-5200

International: 412-317-6060

Replay: https://investor.pacificbiosciences.com

If using the dial-in option, please dial into the call five to ten minutes prior to start time using the appropriate number above and ask to join the "PacBio Q2 Earnings Call."

About PacBio

Pacific Biosciences of California, Inc. is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technology under development stem from two highly differentiated core technologies focused on accuracy, quality and completeness which include our existing HiFi long read sequencing and our emerging SBB® short read sequencing technologies. Our products address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information please visit www.pacb.com and follow @PacBio.

Contacts

Investors:
Todd Friedman
650.521.8450
ir@pacb.com 

Media:
Lizelda Lopez
pr@pacb.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/pacbio-to-report-second-quarter-2022-financial-results-on-august-3-2022-301588485.html

SOURCE Pacific Biosciences of California, Inc.

FAQ

When will PacBio report its Q2 2022 financial results?

PacBio will report its Q2 2022 financial results on August 3, 2022.

What time is PacBio's Q2 2022 earnings call?

The earnings call is scheduled for 5:00 pm ET on August 3, 2022.

How can I access the PacBio earnings call?

The earnings call can be accessed via live webcast on PacBio's investor relations website.

What technologies does PacBio focus on?

PacBio focuses on HiFi long read sequencing and emerging SBB® short read sequencing technologies.

Pacific Biosciences of California, Inc.

NASDAQ:PACB

PACB Rankings

PACB Latest News

PACB Stock Data

547.43M
248.25M
9.32%
84.53%
18.48%
Medical Devices
Laboratory Analytical Instruments
Link
United States of America
MENLO PARK